Literature DB >> 20147445

Primary Sjogren's syndrome: too dry and too tired.

Wan-Fai Ng1, Simon J Bowman.   

Abstract

Chronic fatigue is one of the most prevalent and debilitating symptoms in primary SS (pSS). Approximately 70% of pSS patients suffer from disabling fatigue, which is associated with reduced health-related quality of life. In this article, we review the instruments used for evaluating pSS-related fatigue, our current understanding of the underlying psychosocial and physiological mechanisms of fatigue in pSS and the therapeutic strategies that have been studied in the management of fatigue in pSS.

Entities:  

Mesh：

Year:  2010        PMID： 20147445     DOI： 10.1093/rheumatology/keq009

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


  37 in total

1.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

2.  Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.

Authors:  Maike Jülich; Anna-Maria Kanne; Bettina Sehnert; Stephan Budweiser; Reinhard E Voll; Florian Kollert
Journal:  Clin Rheumatol       Date:  2018-06-01       Impact factor: 2.980

3.  Early gene expression in salivary gland after isoproterenol treatment.

Authors:  Yi Zhou; Hung-I H Chen; A L Lin; H Dang; Karin Haack; Shelley A Cole; Yufei Huang; Haiyang Yu; Yidong Chen; Chih-Ko Yeh
Journal:  J Cell Biochem       Date:  2015-03       Impact factor: 4.429

4.  The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.

Authors:  Jinlin Liu; Zhao Zhao; Yuqiong Zou; Mei Zhang; Yonglie Zhou; Yasong Li; Zhenzhen Pang; Weidong Jin
Journal:  Clin Rheumatol       Date:  2015-01-08       Impact factor: 2.980

Review 5.  Sjögren syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  CMAJ       Date:  2014-02-24       Impact factor: 8.262

6.  Characterization of cognitive dysfunction in Sjögren's syndrome patients.

Authors:  Lynn C Epstein; Gina Masse; Jerold S Harmatz; Tammy M Scott; Athena S Papas; David J Greenblatt
Journal:  Clin Rheumatol       Date:  2013-12-15       Impact factor: 2.980

7.  Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.

Authors:  J C Felger; S W Cole; T W W Pace; F Hu; B J Woolwine; G H Doho; C L Raison; A H Miller
Journal:  Psychol Med       Date:  2011-12-09       Impact factor: 7.723

8.  Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.

Authors:  Samira Tatiyama Miyamoto; Valéria Valim; Luciana Carletti; Wan-Fai Ng; Anselmo José Perez; Dennis William Lendrem; Michael Trennel; Raquel Altoé Giovelli; Laiza Hombre Dias; Érica Vieira Serrano; Alice Mendonça Subtil; Vanessa Cândido Abreu; Jamil Natour
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

9.  Pain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients.

Authors:  Barbara M Segal; Brian Pogatchnik; Lisa Henn; Kyle Rudser; Kathy Moser Sivils
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

Review 10.  Sjögren's syndrome in older patients: aetiology, diagnosis and management.

Authors:  Rada V Moerman; Hendrika Bootsma; Frans G M Kroese; Arjan Vissink
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.